홈MCP워크벤치Skills
홈워크벤치알림마이페이지
Huagongshe 오픈 프로젝트:[email protected]AI 접속: llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.7.8
  1. 홈
  2. /화합물

Buprenorphine

HCID 644073
노트반응

데이터를 보충하는 중입니다. 잠시 후 페이지를 새로 고치면 최신 내용을 볼 수 있습니다

기본 정보이름 및 식별자물성안전 및 규제화학 및 산업관련 반응화합물 노트
부분 구조 검색유사 구조 찾기

기본 정보

CAS
52485-79-7
표준 SMILES
CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1Cc4ccc(O)c5c4[C@@]3(CCN1CC1CC1)[C@H]2O5
InChIKey
RMRJXGBAOAMLHD-IHFGGWKQSA-N
분자식
C29H41NO4
평균 분자량
467.65 g/mol
단동위원소 질량
467.30355879

이름 및 식별자

우선 이름
Buprenorphine
IUPAC
(18R)-17-(Cyclopropylmethyl)-18-[(2S)-2-hydroxy-3,3-dimethylbutan-2-yl]-6-methoxy-5alpha,6beta,14beta-18,19-dihydro-4,5-epoxy-6,14-ethenomorphinan-3-ol
영어명
BUPRENORPHINE
분자식
C29H41NO4
분자량
467.65

이름 및 동의어

BUPRENORPHINE BASEBuprenexBuprenorphine EP Impurity DUM-952rx6029mLepetanTemgesiSubutexNIH-8805Temgesic

데이터베이스 식별자

CAS
52485-79-7
PubChem CID
644073
DTXSID
DTXSID2022705
ChEMBL
CHEMBL511142
ChEBI
CHEBI:3216
UNII
40D3SCR4GZ
EC Number
257-950-6

물성

물리화학적 성질

녹는점
260 · 260-262°C
끓는 점
570.1 °C · 570.1°C (rough estimate)
밀도
1.0953 · 1.0953 (rough estimate)
굴절률
1.629 · 1.6290 (estimate)
인화점
9 ℃ · 9℃
저장 조건
-20 °C · -20°C
용해도
물에 매우 약간 용해되고, 아세톤에 잘 용해되고, 메탄올에 용해되고, 시클로헥산에 약간 용해됩니다. 묽은 산 용액에 용해됩니다.
산도 계수 (pKa)
8.24 · pKa 8.24(H2O t=23.0±0.3) (Uncertain)
EPA
6 · 6,14-Ethenomorphinan-7-methanol, 17-(cyclopropylmethyl)-.alpha.-(1,1-dimethylethyl)-4,5-epoxy-18,19-dihydro-3-hydroxy-6-methoxy-.alpha.-methyl-, (.alpha.S,5.alpha.,7.alpha.)- (52485-79-7)

화학적 성질

White Solid

안전 및 규제

안전 정보는 참고용이며, 공급업체의 물질안전보건자료(SDS), 관련 법규 및 전문가 평가를 대체하지 않습니다.

안전 데이터

wgk
1
ridadr
UN1230 - class 3 - PG 2 - Methanol, solution
독성
LD50 oral in mouse: 260mg/kg
risk_code
11-23/24/25-39/23/24/25
hazard_code
F,T
safety_code
16-36/37-45-7

화학 및 산업

응용 분야 · 2건

용도Controllled substance (narcotic). Analgesic that demonstrates narcotic agonist-antagonist properties.

일반 설명Buprenorphine is a semisynthetic, highly lipophilic opiate derivedfrom thebaine. Pharmacologically, it is classified as amixed μ-agonist/antagonist (a partial agonist) and a weak κ-antagonist. It has a high affinity for the μ-receptors(1,000 times greater than morphine) and a slow dissociationrate leading to its long duration of action (6–8 hours). Atrecommended doses, it acts as an agonist at the μ-receptorwith approximately 0.3 mg IV equianalgesic to 10 mg of IVmorphine. One study in humans found that buprenorphine displaysa ceiling effect to the respiratory depression, but not theanalgesic effect over a dose range of 0.05 to 0.6 mg.In practice,this makes buprenorphine a safer opiate (when usedalone) than pure μ-agonists. Relatively few deaths frombuprenorphine overdose (when used alone) have been reported.113 The tight binding of the drug to the receptor also hasled to mixed reports on the effectiveness of using naloxone toreverse the respiratory depression. In animal studies, normaldoses of the pure antagonist naloxone were unable to removebuprenorphine from the receptor site and precipitate withdrawal.In a human study designed to precipitate withdrawalfrom buprenorphine, a naloxone dose (mean=35 mg) 100times the dose usually needed to precipitate withdrawal inmethadone-dependent subjects was used. For comparison, approximately0.3 mg, 4 mg, 4 mg, and 10 mg of naloxonewould be required to precipitate withdrawal from heroin, butorphanol,nalbuphine, or pentazocine respectively.

추가 설명 · 1건

정의ChEBI: A morphinane alkaloid that is 7,8-dihydromorphine 6-O-methyl ether in which positions 6 and 14 are joined by a -CH2CH2- bridge, one of the hydrogens of the N-methyl group is su stituted by cyclopropyl, and a hydrogen at position 7 is substituted by a 2-hydroxy-3,3-dimethylbutan-2-yl group.

관련 반응

0건
반응 기록 만들기

현재 필터 조건에 해당하는 반응 기록이 없습니다.

화합물 노트

불러오는 중…

이 페이지에서기본 정보이름 및 식별자물성안전 및 규제화학 및 산업관련 반응화합물 노트